Research Grade Cugrastomig
Research Grade Cugrastomig  Research Grade Cugrastomig 

Research Grade Cugrastomig

  • Catalog number: BS12359
  • Availability: In Stock
  • $482.00

  • Ex Tax: $482.00


Available Options

Qty
Description: Cugrastomig (BS12359) is a research-grade recombinant antibody targeting CD223. Produced in mammalian cells with native-like glycosylation.
Highlights:
• Research Grade — For PK/PD studies, assay development, and ADA research.
• Native Glycosylation — Mammalian expression ensures native-like patterns.
Host species: Humanized
Isotype: ImmunoglobulinIGfusedto2scFv(H-gamma1-scFvhk_L'-kappa)dimer
Species reactivity: Human
Immunogen:
Form: Liquid
Storage instructions:
Storage buffer: 0.01M PBS, pH7.4.
Concentration: 1mg/ml
Purity: >95% as determined by SDS-PAGE.
Clonality: Monoclonal
Applications: Research Grade Biosimilar
Target: FDC,LAG3,Lymphocyteactivationgene3protein,CD223,sLAG-3,LAG-3,Programmedcelldeathprotein1,ProteinPD-1,hPD-1,PD1,PDCD1,CD279
Purification: Protein A/G purified from cell culture supernatant.
Endotoxin level: <1EU/mg, determined by LAL gel clotting assay
Expression system: Mammalian Cells
Stability and Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names: Bispecific,Tetravalent,CAS:2852680-10-3
Note: For research use only. Not suitable for clinical or therapeutic use.

Images

  • Bioactivity for Research Grade Cugrastomig
    Bioactivity

    Detects recombinant PD1 (Catalog No: PH12292) in indirect ELISA.

  • Bioactivity for Research Grade Cugrastomig
    Bioactivity

    Detects recombinant LAG3 (Catalog No: PH11099) in indirect ELISA.

Be the first to write a review for this product.

Write a review

Note: HTML is not translated!
Bad           Good